Novartis, NHS England to collaborate on cardiovascular diseases
The collaboration includes three projects that tackle the CVD challenge and provides enhanced opportunities for life science sector…
SAB, CSL Behring enter into research collaboration
09 Jan 20The partnership is aimed at exploring potential new therapies encompassing autoimmune, infectious and idiopathic disorders, using SAB’s DiversitAb…
CytoDyn, Vyera partner to market leronlimab in US for HIV treatment
18 Dec 19CytoDyn intends to obtain FDA approval for leronlimab in combination therapy, and file a biologics license application (BLA)…
GE Healthcare, UMMS to open Viral Vector manufacturing facility
17 Dec 19The new manufacturing facility is designed to cover an area of 3,220ft² and feature a good laboratory practice…
Novartis partners with AWS to streamline business operations
05 Dec 19Healthcare firm Novartis and AWS will jointly develop ‘Insight Centres’ to provide real-time visibility across the network of…
ViiV Healthcare to develop N6LS for treatment and prevention of HIV
22 Nov 19bNAbs are the antibodies capable of recognising and blocking the entry of different strains of HIV into healthy…
Dicerna, Novo Nordisk partner to discover and develop RNAi therapies
19 Nov 19Novo Nordisk will pay $175m as upfront payment, $50m as an equity investment in Dicerna at a premium,…
Cardinal Health collaborates with TCS to transform its IT operating model
14 Nov 19TCS will provide its Enterprise Agile vision and Machine-First Delivery Model (MFDM), for Cardinal Health’s new operating model
Boehringer Ingelheim, Lilly expand collaboration to focus on Jardiance
05 Nov 19Boehringer Ingelheim and Eli Lilly have been developing and commercialising Trajenta (linagliptin) and Basaglar (insulin glargine)
Cynata, University of Sydney collaborate on Phase II clinical trial of Cymerus MSCs
07 Oct 19Cynata retains all the commercial rights to use the Cymerus MSCs in osteoarthritis and would pay up to…